<DOC>
	<DOCNO>NCT01798173</DOCNO>
	<brief_summary>Available data allow carcinogenesis mechanism cirrhotic patient well understood absence study take account recognise factor . A large scale clinical , biochemical molecular study potentially relevant understanding nutrition , physical activity , body weight metabolic syndrome whatever etiology underlie cirrhosis . It open new perspective : - prevention hepatocellular carcinoma development cirrhotic patient dietary counsel therapeutic metabolic syndrome , - early screening hepatocellular carcinoma cirrhotic patient spectroscopic technology later proteomic study result improvement hepatocellular carcinoma prognosis .</brief_summary>
	<brief_title>Environmental , Metabolic Nutritional Factors Hepatocellular Carcinoma Cirrhotic Patients</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<criteria>Cases control male female age 35 old , give inform consent participate study . * Hepatocellular carcinoma case : All hepatocellular carcinoma case evolve cirrhotic liver , whatever etiology cirrhosis , include . Criteria diagnosis hepatocellular carcinoma define European Association Study Liver ( EASL ) ( Bruix J , J Hepatol 2001 ) : Focal hepatic lesion â‰¥ 2cm diameter : alphafetoprotein ( AFP ) &lt; 400 ng/ml : nodule identify least two coincident morphologic examination ( abdominal US , angiography , CT MRI ) arterial hypervascularisation least one image modality AFP &gt; 400 ng/ml : lesion see single image modality Focal hepatic lesion &lt; 2 cm diameter : lesion 1 2 cm diameter : use fineneedle aspiration biopsy lesion &lt; 1 cm : serial abdominal US every 3 month lesion exceed 1 cm size biopsy become possible . Such case include diagnosis confirmation . Whatever size focal lesion , diagnosis cirrhosis make accord criterion cirrhotic group control . * Cirrhotic control patient : All patient cirrhosis , whatever etiology , include . The diagnosis cirrhosis rely : Histological confirmation liver biopsy absence biopsy : patient free portal thrombosis Doppler imaging , presence portal hypertension ascertain biological ( tricytopenia ) , morphologic ( abdominal US , CT MRI ) , hepatic venous pressure measurement upper endoscopy ( mosaic gastropathy , varix ) . patient portal thrombosis , presence portal hypertension associate : Clinical ( hepatomegaly clinical evidence hepatocellular failure : spider naevi , palmar erythema , white mail , gynecomastia ) morphological sign cirrhosis ( enlarge liver , nodular surface , sharp low edge ) . And/or biological sign hepatocellular failure ( TP &lt; 70 % , low albuminemia ) And/or sinusoidal block assess liver venous gradient &gt; 18mmHG In present state knowledge , fibrotest value 4 fibroscan value &gt; 12.5 kilopascal . Without clinical biological sign consider diagnosis criterion cirrhosis chronic viral C hepatitis . The lack hepatocellular carcinoma cirrhotic patient inclusion assess good quality image examination ( abdominal US , CT scan MRI ) AFP 100 ng/ml . age 35 year cancer evolution HIV infection Major somatic pr psychiatric illness compatible inclusion study No hepatocellular carcinoma primary liver cancer .</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Hepatocellular carcinoma</keyword>
	<keyword>Cirrhosis</keyword>
	<keyword>Environmental risk factor</keyword>
	<keyword>Nutrition</keyword>
	<keyword>Metabolic syndrome</keyword>
</DOC>